Related Experiment Video
Updated: Jul 4, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
HIF and reactive oxygen species regulate oxidative phosphorylation in cancer
Eric Hervouet1, Alena Cízková, Jocelyne Demont
1Centre de Génétique Moléculaire et Cellulaire, UMR 5534, Centre National de la Recherche Scientifique, Claude Bernard University of Lyon 1, 43 Boulevard du onze novembre, 69622 Villeurbanne, Cedex, France.
Abstract:
A decrease in oxidative phosphorylation (OXPHOS) is characteristic of many cancer types and, in particular, of clear cell renal carcinoma (CCRC) deficient in von Hippel-Lindau (vhl) gene. In the absence of functional pVHL, hypoxia-inducible factor (HIF) 1-alpha and HIF2-alpha subunits are stabilized, which induces the transcription of many genes including those involved in glycolysis and reactive oxygen species (ROS) metabolism. Transfection of these cells with vhl is known to restore HIF-alpha subunit degradation and to reduce glycolytic genes transcription. We show that such transfection with vhl of 786-0 CCRC (which are devoid of HIF1-alpha) also increased the content of respiratory chain subunits. However, the levels of most transcripts encoding OXPHOS subunits were not modified. Inhibition of HIF2-alpha synthesis by RNA interference in pVHL-deficient 786-0 CCRC also restored respiratory chain subunit content and clearly demonstrated a key role of HIF in OXPHOS regulation. In agreement with these observations, stabilization of HIF-alpha subunit by CoCl(2) decreased respiratory chain subunit levels in CCRC cells expressing pVHL. In addition, HIF stimulated ROS production and mitochondrial manganese superoxide dismutase content. OXPHOS subunit content was also decreased by added H(2)O(2.) Interestingly, desferrioxamine (DFO) that also stabilized HIF did not decrease respiratory chain subunit level. While CoCl(2) significantly stimulates ROS production, DFO is known to prevent hydroxyl radical production by inhibiting Fenton reactions. This indicates that the HIF-induced decrease in OXPHOS is at least in part mediated by hydroxyl radical production.
Insights
Hypoxia-inducible factor (HIF) regulates oxidative phosphorylation (OXPHOS) in clear cell renal carcinoma (CCRC). HIF stabilization decreases OXPHOS, a process partly mediated by hydroxyl radical production, impacting cancer cell metabolism.
Area of Science:
- Oncology
- Cellular Metabolism
- Biochemistry
Background:
- Clear cell renal carcinoma (CCRC) is characterized by decreased oxidative phosphorylation (OXPHOS).
- This metabolic shift is linked to the deficiency of the von Hippel-Lindau (vhl) gene and stabilization of hypoxia-inducible factor (HIF) subunits.
- Stabilized HIF promotes glycolysis and alters reactive oxygen species (ROS) metabolism.
Purpose of the Study:
- To investigate the role of HIF in regulating OXPHOS in CCRC.
- To elucidate the mechanisms by which HIF influences mitochondrial function and ROS production in CCRC cells.
Main Methods:
- Utilized vhl gene transfection in pVHL-deficient CCRC cells (786-0).
- Employed RNA interference to inhibit HIF2-alpha synthesis.
- Stabilized HIF-alpha using CoCl(2) and desferrioxamine (DFO) in CCRC cells with and without pVHL expression.
Main Results:
- vhl transfection restored respiratory chain subunit content in CCRC cells, despite unchanged transcript levels.
- HIF2-alpha inhibition also restored respiratory chain subunit content, confirming HIF's regulatory role.
- HIF stabilization by CoCl(2) decreased respiratory chain subunit levels and increased ROS production, an effect partly mediated by hydroxyl radicals.
Conclusions:
- HIF plays a critical role in regulating OXPHOS subunit content in CCRC.
- The HIF-induced decrease in OXPHOS is, in part, mediated by hydroxyl radical production.
- Targeting HIF and ROS metabolism presents a potential therapeutic strategy for CCRC.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
